MAA
SRPT icon

Managed Account Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Managed Account Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-571
Closed -$8K – 3057
2014
Q4 		$8K Sell
571
-16,683
-97% -$282K ﹤0.01% 2643
2014
Q3 		$364K Sell
17,254
-17,401
-50% -$393K ﹤0.01% 2229
2014
Q2 		$1.03M Sell
34,655
-1,810
-5% -$57.2K ﹤0.01% 1998
2014
Q1 		$876K Buy
36,465
+5,028
+16% +$128K ﹤0.01% 1990
2013
Q4 		$640K Buy
31,437
+3,009
+11% +$89.4K ﹤0.01% 2013
2013
Q3 		$1.34M Sell
28,428
-855
-3% -$32.9K ﹤0.01% 1809
2013
Q2 		$1.11M Buy
+29,283
New +$1.05M ﹤0.01% 1840

Other funds holding SRPT

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Managed Account Advisors's SRPT Position: Q1 2015 in Review

Managed Account Advisors sold out of Sarepta Therapeutics (SRPT) in Q1 2015, closing a stake of 571 shares — an estimated $8K sold.

Managed Account Advisors first reported a position in SRPT in Q2 2013 and held it in 7 quarters. The position peaked at $1.34M in Q3 2013. 114 funds tracked by Wall St. Rank hold SRPT as of Q1 2015.

  • Managed Account Advisors reported no remaining Sarepta Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Managed Account Advisors sold 571 Sarepta Therapeutics shares in Q1 2015, an estimated $8K.
  • Managed Account Advisors first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 7 quarters.
  • Managed Account Advisors's Sarepta Therapeutics position peaked at $1.34M in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2015.

Based on Managed Account Advisors's 13F filing for Q1 2015, filed 15 May 2015.